The importance of doing trials right while doing the right trials
- PMID: 22072734
- PMCID: PMC4494860
- DOI: 10.1158/1078-0432.CCR-11-2586
The importance of doing trials right while doing the right trials
Abstract
Effort is being expended in investigating efficiency measures (i.e., doing trials right) through achievement of accrual and endpoint goals for clinical trials. It is time to assess the impact of such trials on meeting the critical needs of cancer patients by establishing effectiveness measures (i.e., doing the right trials).
© 2011 AACR.
Comment on
-
Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology Groups.Clin Cancer Res. 2012 Jan 1;18(1):256-62. doi: 10.1158/1078-0432.CCR-11-1633. Epub 2011 Oct 5. Clin Cancer Res. 2012. PMID: 21976533 Free PMC article.
References
-
- Tam VC, Tannock IF, Massey C, Rauw J, Krzyzanowska MK. Compendium of Unpublished Phase III Trials in Oncology: Characteristics and Impact on Clinical Practice. Journal of Clinical Oncology. 2011;29:3133. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
